Overexpression of IL-10 enhances the efficacy of human umbilical-cord-derived mesenchymal stromal cells in E. Coli pneumosepsis

Journal of Clinical Medicine

Volumn 8, Issue 6, 2019, Pages

  Jerkic, Mirjana ^a   Masterson, Claire ^b   Ormesher, Lindsay ^a   Gagnon, Stéphane ^a   Goyal, Sakshi ^a   Rabani, Razieh ^a   Otulakowski, Gail ^c   Zhang, Haibo ^a   Kavanagh, Brian P ^c,d   Laffey, John G ^b,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Macrophage; Mesenchymal stromal cell; Phagocytosis; Pneumonia; Sepsis

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ARACHIDONATE 15 LIPOXYGENASE; BETA ACTIN; CD34 ANTIGEN; ENDOGLIN; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 6; LIPOXIN A; LIPOXYGENASE; LIPOXYGENASE A4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; PROSTAGLANDIN E2; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; THY 1 MEMBRANE GLYCOPROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; BLOOD OXYGENATION; CELL INFILTRATION; CELL STRUCTURE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI PNEUMONIA; FLOW CYTOMETRY; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE FUNCTION; MALE; MESENCHYMAL STROMA CELL; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PROTEIN EXPRESSION; RAT; SEPSIS; UMBILICAL CORD BLOOD CELL; WESTERN BLOTTING;

EID: 85072172196     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm8060847     Document Type: Article

References (32)

1. Keane, C.; Jerkic, M.; Laffey, J.G. Stem cell-based therapies for sepsis. Anesthesiology 2017, 127, 1017–1034.
2. Laffey, J.G.; Matthay, M.A. Fifty years of research in ARDS: Cell-based therapy for acute respiratory distress syndrome, biology and potential therapeutic value. Am. J. Respir. Crit. Care Med. 2017, 196, 266–273.
3. Curley, G.F.; Jerkic, M.; Dixon, S.; Hogan, G.; Masterson, C.; O’Toole, D.; Devaney, J.; Laffey, J.G. Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli-induced acute respiratory distress syndrome. Crit. Care Med. 2017, 45, e202–e212.
4. Curley, G.; Hayes, M.; Ansari, B.; Shaw, G.; Ryan, A.; Barry, F.; O’Brien, T.; O’Toole, D.; Laffey, J. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012, 67, 496–501.
5. Curley, G.F.; Ansari, B.; Hayes, M.; Devaney, J.; Masterson, C.; Ryan, A.; Barry, F.; O’Brien, T.; O’Toole, D.; Laffey, J.G. Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury. Anesthesiology 2013, 118, 924–932.
6. Devaney, J.; Horie, S.; Masterson, C.; Elliman, E.; Barry, F.; O’Brien, T.; Curley, G.; Toole, D.; Laffey, J. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 2015, 70, 625–635.
7. Hayes, M.; Curley, G.F.; Masterson, C.; Devaney, J.; O’Toole, D.; Laffey, J.G. Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilatorinduced lung injury. Intensive Care Med. Exp. 2015, 3, 29.
8. Hayes, M.; Masterson, C.; Devaney, J.; Barry, F.; Elliman, S.; O’Brien, T.; O’Toole, D.; Curley, G.F.; Laffey, J.G. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilatorinduced lung injury in the rat. Anesthesiology 2015, 122, 363–373.
9. Oggu, G.S.; Sasikumar, S.; Reddy, N.; Ella, K.K.R.; Rao, C.M.; Bokara, K.K. Gene delivery approaches for mesenchymal stem cell therapy: Strategies to increase efficiency and specificity. Stem Cell Rev. 2017, 13, 725– 740.
10. Zhao, H.Q.; Li, W.M.; Lu, Z.Q.; Sheng, Z.Y.; Yao, Y.M. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis. J. Interferon Cytokine Res. 2015, 35, 242– 251.
11. Li, H.D.; Zhang, Q.X.; Mao, Z.; Xu, X.J.; Li, N.Y.; Zhang, H. Exogenous interleukin-10 attenuates hyperoxiainduced acute lung injury in mice. Exp. Physiol. 2015, 100, 331–340.
12. Machuca, T.N.; Cypel, M.; Bonato, R.; Yeung, J.C.; Chun, Y.M.; Juvet, S.; Guan, Z.; Hwang, D.M.; Chen, M.; Saito, T.; et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model. Hum. Gene Ther. 2017, 28, 757–765.
13. Wang, C.; Lv, D.; Zhang, X.; Ni, Z.A.; Sun, X.; Zhu, C. Interleukin-10-overexpressing mesenchymal stromal cells induce a series of regulatory effects in the inflammatory system and promote the survival of endotoxin-induced acute lung injury in mice model. DNA Cell Biol. 2018, 37, 53–61.
14. Manning, E.; Pham, S.; Li, S.; Vazquez-Padron, R.I.; Mathew, J.; Ruiz, P.; Salgar, S.K. Interleukin-10 delivery via mesenchymal stem cells: A novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum. Gene Ther. 2010, 21, 713–727.
15. Meng, X.; Li, J.; Yu, M.; Yang, J.; Zheng, M.; Zhang, J.; Sun, C.; Liang, H.; Liu, L. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction. J. Cell Physiol. 2018, 233, 587–595.
16. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M.M.; Davies, J.E. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 2005, 23, 220–229.
17. Sarugaser, R.; Ennis, J.; Stanford, W.L.; Davies, J.E. Isolation, propagation, and characterization of human umbilical cord perivascular cells (HUCPVCs). Methods Mol. Biol. 2009, 482, 269–279.
18. O’Croinin, D.F.; Nichol, A.D.; Hopkins, N.; Boylan, J.; O’Brien, S.; O’Connor, C.; Laffey, J.G.; McLoughlin, P. Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury. Crit. Care Med. 2008, 36, 2128–2135.
19. Costello, J.; Higgins, B.; Contreras, M.; Chonghaile, M.N.; Hassett, P.; O’Toole, D.; Laffey, J.G. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit. Care Med. 2009, 37, 2412–2420.
20. Higgins, B.D.; Costello, J.; Contreras, M.; Hassett, P.; O’Toole, D.; Laffey, J.G. Differential effects of buffered hypercapnia versus hypercapnic acidosis on shock and lung injury induced by systemic sepsis. Anesthesiology 2009, 111, 1317–1326.
21. Laffey, J.G.; Honan, D.; Hopkins, N.; Hyvelin, J.M.; Boylan, J.F.; McLoughlin, P. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 2004, 169, 46–56.
22. Jerkic, M.; Peter, M.; Ardelean, D.; Fine, M.; Konerding, M.A.; Letarte, M. Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in Endoglin heterozygous mice. Inflamm. Bowel Dis. 2010, 16, 1859–1870.
23. Canton, J.; Khezri, R.; Glogauer, M.; Grinstein, S. Contrasting phagosome pH regulation and maturation in human M1 and M2 macrophages. Mol. Biol. Cell 2014, 25, 3330–3341.
24. Rabani, R.; Volchuk, A.; Jerkic, M.; Ormesher, L.; Garces-Ramirez, L.; Canton, J.; Masterson, C.; Gagnon, S.; Tatham, K.C.; Marshall, J.; et al. Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis. Eur. Respir. J. 2018, 51, doi:10.1183/13993003.02021-2017.
25. Masterson, C.; Devaney, J.; Horie, S.; O’Flynn, L.; Deedigan, L.; Elliman, S.; Barry, F.; O’Brien, T.; O’Toole, D.; Laffey, J.G. Syndecan-2-positive, bone marrow-derived human mesenchymal stromal cells attenuate bacterial-induced acute lung injury and enhance resolution of ventilator-induced lung injury in rats. Anesthesiology 2018, 129, 502–516.
26. Krasnodembskaya, A.; Song, Y.; Fang, X.; Gupta, N.; Serikov, V.; Lee, J.; Matthay, M. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010, 28, 2229–2238.
27. Jackson, M.V.; Morrison, T.J.; Doherty, D.F.; McAuley, D.F.; Matthay, M.A.; Kissenpfennig, A.; O’Kane, C.M.; Krasnodembskaya, A.D. Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 2016, 34, 14.
28. McAuley, D.F.; Curley, G.F.; Hamid, U.I.; Laffey, J.G.; Abbott, J.; McKenna, D.H.; Fang, X.; Matthay, M.A.; Lee, J.W. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am. J. Physiol Lung Cell Mol. Physiol. 2014, 306, L809–L815.
29. Islam, M.N.; Das, S.R.; Emin, M.T.; Wei, M.; Sun, L.; Westphalen, K.; Rowlands, D.J.; Quadri, S.K.; Bhattacharya, S.; Bhattacharya, J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 2012, 18, 759–765.
30. Fang, X.; Abbott, J.; Cheng, L.; Colby, J.K.; Lee, J.W.; Levy, B.D.; Matthay, M.A. Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. J. Immunol. 2015, 195, 7.
31. Varkouhi, A.; Jerkic, M.; Ormesher, L.; Gagnon, S.; Goyal, S.; Rabani, R.; Chen, P.; Gu, F.; dos Santos, C.; Curley, G.F.; et al. Extracellular vesicles derived from Interferon-g primed human umbilical cord derived mesenchymal stromal cells demonstrate enhanced efficacy in pneumonia induced ARDS. Anesthesiology 2019, 130, 778–790.
32. Chen, W.; Li, M.; Cheng, H.; Yan, Z.; Cao, J.; Pan, B.; Sang, W.; Wu, Q.; Zeng, L.; Li, Z.; et al. Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells. Cell Biochem. Biophys. 2013, 67, 1181–1191.